logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Kornelia Polyak

This inventor holds 5 USPTO granted patents. Top assignees: Fred Hutchinson Cancer Center, Sloan-Kettering Institute for Cancer Research, Other. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kornelia Polyak. Retrieved from https://idiyas.com/inventor/kornelia-polyak-1c0jejmp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 126(Granted Patents)


Location History:

  • New York, NY (US) (1997)
  • Roslindale, MA (US) (2001)
  • Baltimore, MD (US) (2001 - 2003)

Company Filing History:

goldMedal1 out of 309 
 
Fred Hutchinson Cancer Center
 patents
silverMedal1 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents
bronzeMedal4 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2003

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6635450 - Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents (2003-10-21),
2. 6355774 - Isolated p27 protein (2002-03-12),
3. 6316208 - Methods for determining isolated p27 protein levels and uses thereof (2001-11-13),
4. 6242575 - Antibodies for detecting p27 protein (2001-06-05),
5. 5688665 - Isolated nucleic acid molecules encoding the p27 KIP-1 protein (1997-11-18),

Title: Kornelia Polyak: Innovator in Cancer Research

Introduction

Kornelia Polyak is a prominent inventor based in Baltimore, MD, known for her significant contributions to cancer research. With a total of five patents to her name, she has made remarkable strides in understanding and treating various disorders related to cell proliferation.

Latest Patents

Among her latest patents is the isolated P27 protein, which has an apparent molecular weight of about 27 kD. This protein is capable of binding to and inhibiting the activation of a cyclin E-Cdk2 complex. Additionally, she has developed nucleic acid molecules encoding the P27 protein, along with methods for identifying agents that act on this protein. These innovations include in vitro assays for discovering agents that affect the activity of P27, as well as methods for diagnosing and treating both hypoproliferative and hyperproliferative disorders.

Career Highlights

Kornelia Polyak has had a distinguished career, working at notable institutions such as the Fred Hutchinson Cancer Center. Her research has focused on the mechanisms of cancer and the development of therapeutic strategies to combat the disease.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues, including James M. Roberts and Joan Massagué, who have contributed to her research endeavors.

Conclusion

Kornelia Polyak's innovative work in cancer research and her patented discoveries highlight her role as a leading inventor in the field. Her contributions continue to pave the way for advancements in diagnosing and treating cancer-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…